Overview

Study of ONO-2506 in Patients With Acute Ischemic Stroke

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd